Passage BIO, Inc. (PASG) Insider Trading -- Recent Executive & Director Transactions

6 insiders reported 36 Form 4 transactions for Passage BIO, Inc. (PASG) over the past 18 months (most recent 2026-01-12). Recent activity: Borthwick Kathleen (CFO) Buy 5,000 shares, Borthwick Kathleen (CFO) Sell 2,062 shares, Chou William (PRESIDENT AND CEO) Buy 10,000 shares, Chou William (PRESIDENT AND CEO) Sell 4,076 shares, Nichols Weston (Insider) Buy 325 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-01-12Borthwick KathleenCFOBuy5,000$0
2026-01-12Borthwick KathleenCFOSell2,062$38,023
2026-01-12Chou WilliamPRESIDENT AND CEOBuy10,000$0
2026-01-12Chou WilliamPRESIDENT AND CEOSell4,076$75,161
2025-09-15Nichols WestonInsiderBuy325$2,262
2025-09-15Lynx1 Capital Management LPInsiderBuy325$2,262
2025-09-15Nichols WestonInsiderBuy19,783$138,283
2025-09-15Lynx1 Capital Management LPInsiderBuy19,783$138,283
2025-09-15Nichols WestonInsiderBuy11,900$83,181
2025-09-15Lynx1 Capital Management LPInsiderBuy11,900$83,181
2025-07-24Nichols WestonInsiderBuy49,302$282,993
2025-07-24Lynx1 Capital Management LPInsiderBuy13,123$71,389
2025-07-24Nichols WestonInsiderBuy13,123$71,389
2025-07-24Lynx1 Capital Management LPInsiderBuy49,302$282,993
2025-07-24Nichols WestonInsiderBuy66,423$379,275
2025-07-24Lynx1 Capital Management LPInsiderBuy66,423$379,275
2025-06-26ORBIMED ADVISORS LLCInsiderSell231,600$0
2025-06-26OrbiMed Capital GP VII LLCInsiderSell231,600$0
2025-06-26ORBIMED ADVISORS LLCInsiderSell138,800$0
2025-06-26OrbiMed Capital GP VII LLCInsiderSell138,800$0
2025-06-26ORBIMED ADVISORS LLCInsiderSell213,257$0
2025-06-26OrbiMed Capital GP VII LLCInsiderSell213,257$0
2025-04-24ORBIMED ADVISORS LLCInsiderSell78,049$0
2025-04-24OrbiMed Capital GP VII LLCInsiderSell78,049$0
2025-04-24ORBIMED ADVISORS LLCInsiderSell89,328$0

Source: SEC Form 4 filings · as of 2026-01-12